Congenital Defects of Thyroid Hormone Synthesis

Genetic Diagnosis of Endocrine Disorders

Volumn , Issue , 2010, Pages

  Grasberger, Helmut ^a   Refetoff, Samuel ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Congenital hypothyroidism; Dehalogenase; Dual oxidase; Genetics; Iodide; Pendred syndrome; Thyroglobulin; Thyroid; Thyroid peroxidase

Indexed keywords

EID: 80052276762     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374430-2.00008-0     Document Type: Chapter

References (56)

1. Clerc J., Monpeyssen H., Chevalier A., et al. Scintigraphic imaging of paediatric thyroid dysfunction. Horm. Res. 2008, 70:1-13.
2. Stanbury J.B., Chapman E.M. Congenital hypothyroidism with goitre. Absence of an iodide-concentrating mechanism. Lancet 1960, 1:1162-1165.
3. Dai G., Levy O., Carrasco N. Cloning and characterization of the thyroid iodide transporter. Nature 1996, 379:458-460.
4. Fujiwara H., Tatsumi K., Miki K., et al. Congenital hypothyroidism caused by a mutation in the Na+/I- symporter. Nat. Genet. 1997, 16:124-125.
5. Fujiwara H., Tatsumi K., Tanaka S., et al. A novel V59E missense mutation in the sodium iodide symporter gene in a family with iodide transport defect. Thyroid 2000, 10:471-474.
6. Kosugi S., Inoue S., Matsuda A., et al. Novel, missense and loss-of-function mutations in the sodium/iodide symporter gene causing iodide transport defect in three Japanese patients. J. Clin. Endocrinol. Metab. 1998, 83:3373-3376.
7. Szinnai G., Kosugi S., Derrien C., et al. Extending the clinical heterogeneity of iodide transport defect (ITD): a novel mutation R124H of the sodium/iodide symporter gene and review of genotype-phenotype correlations in ITD. J. Clin. Endocrinol. Metab. 2006, 91:1199-1204.
8. Pohlenz J., Rosenthal I.M., Weiss R.E., et al. Congenital hypothyroidism due to mutations in the sodium/iodide symporter. Identification of a nonsense mutation producing a downstream cryptic 3' splice site. J. Clin. Invest. 1998, 101:1028-1035.
9. Pohlenz J., Medeiros-Neto G., Gross J.L., et al. Hypothyroidism in a Brazilian kindred due to iodide trapping defect caused by a homozygous mutation in the sodium/iodide symporter gene. Biochem. Biophys. Res. Commun. 1997, 240:488-491.
10. Kosugi S., Bhayana S., Dean H.J. A novel mutation in the sodium/iodide symporter gene in the largest family with iodide transport defect. J. Clin. Endocrinol. Metab. 1999, 84:3248-3253.
11. Kosugi S., Okamoto H., Tamada A., et al. A novel peculiar mutation in the sodium/iodide symporter gene in Spanish siblings with iodide transport defect. J. Clin. Endocrinol. Metab. 2002, 87:3830-3836.
12. Tonacchera M., Agretti P., de Marco G., et al. Congenital hypothyroidism due to a new deletion in the sodium/iodide symporter protein. Clin. Endocrinol. (Oxf.) 2003, 59:500-506.
13. Everett L.A., Glaser B., Beck J.C., et al. Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat. Genet. 1997, 17:411-422.
14. Pendred V. Deaf-mutism and goitre. Lancet 1896, 2:532.
15. Reardon W., Coffey R., Phelps P.D., et al. Pendred syndrome - 100 years of under-ascertainment?. QJM 1997, 90:443-447.
16. Hutchin T., Coy N.N., Conlon H., et al. Assessment of the genetic causes of recessive childhood non-syndromic deafness in the UK - implications for genetic testing. Clin. Genet. 2005, 68:506-512.
17. Banghova K., Al Taji E., Cinek O., et al. Pendred syndrome among patients with congenital hypothyroidism detected by neonatal screening: identification of two novel PDS/SLC26A4 mutations. Eur. J. Pediatr. 2008, 167:777-783.
18. Denoyelle F., Weil D., Maw M.A., et al. Prelingual deafness: high prevalence of a 30delG mutation in the connexin 26 gene. Hum. Mol. Genet. 1997, 6:2173-2177.
19. Albert S., Blons H., Jonard L., et al. SLC26A4 gene is frequently involved in nonsyndromic hearing impairment with enlarged vestibular aqueduct in Caucasian populations. Eur. J. Hum. Genet. 2006, 14:773-779.
20. Campbell C., Cucci R.A., Prasad S., et al. Pendred syndrome, DFNB4, and PDS/SLC26A4 identification of eight novel mutations and possible genotype-phenotype correlations. Hum. Mutat. 2001, 17:403-411.
21. Coyle B., Reardon W., Herbrick J.A., et al. Molecular analysis of the PDS gene in Pendred syndrome. Hum. Mol. Genet. 1998, 7:1105-1112.
22. Tsukamoto K., Suzuki H., Harada D., et al. Distribution and frequencies of PDS (SLC26A4) mutations in Pendred syndrome and nonsyndromic hearing loss associated with enlarged vestibular aqueduct: a unique spectrum of mutations in Japanese. Eur. J. Hum. Genet. 2003, 11:916-922.
23. Pera A., Dossena S., Rodighiero S., et al. Functional assessment of allelic variants in the SLC26A4 gene involved in Pendred syndrome and nonsyndromic EVA. Proc. Natl. Acad. Sci. USA 2008, 105:18608-18613.
24. Degroot L.J., Stanbury J.B. The syndrome of congenital goiter with butanol-insoluble serum iodine. Am. J. Med. 1959, 27:586-595.
25. Ieiri T., Cochaux P., Targovnik H.M., et al. A 3' splice site mutation in the thyroglobulin gene responsible for congenital goiter with hypothyroidism. J. Clin. Invest. 1991, 88:1901-1905.
26. Rivolta C.M., Targovnik H.M. Molecular advances in thyroglobulin disorders. Clin. Chim. Acta. 2006, 374:8-24.
27. Hishinuma A., Fukata S., Nishiyama S., et al. Haplotype analysis reveals founder effects of thyroglobulin gene mutations C1058R and C1977S in Japan. J. Clin. Endocrinol. Metab. 2006, 91:3100-3104.
28. Kanou Y., Hishinuma A., Tsunekawa K., et al. Thyroglobulin gene mutations producing defective intracellular transport of thyroglobulin are associated with increased thyroidal type 2 iodothyronine deiodinase activity. J. Clin. Endocrinol. Metab. 2007, 92:1451-1457.
29. Stanbury J.B., Hedge A.N. A study of a family of goitrous cretins. J. Clin. Endocrinol. Metab. 1950, 10:1471-1484.
30. Kimura S., Kotani T., McBride O.W., et al. Human thyroid peroxidase: complete cDNA and protein sequence, chromosome mapping, and identification of two alternately spliced mRNAs. Proc. Natl. Acad. Sci. USA 1987, 84:5555-5559.
31. Abramowicz M.J., Targovnik H.M., Varela V., et al. Identification of a mutation in the coding sequence of the human thyroid peroxidase gene causing congenital goiter. J. Clin. Invest. 1992, 90:1200-1204.
32. Rodrigues C., Jorge P., Soares J.P., et al. Mutation screening of the thyroid peroxidase gene in a cohort of 55 Portuguese patients with congenital hypothyroidism. Eur. J. Endocrinol. 2005, 152:193-198.
33. Avbelj M., Tahirovic H., Debeljak M., et al. High prevalence of thyroid peroxidase gene mutations in patients with thyroid dyshormonogenesis. Eur. J. Endocrinol. 2007, 156:511-519.
34. Bakker B., Bikker H., Vulsma T., et al. Two decades of screening for congenital hypothyroidism in The Netherlands: TPO gene mutations in total iodide organification defects (an update). J. Clin. Endocrinol. Metab. 2000, 85:3708-3712.
35. Fugazzola L., Cerutti N., Mannavola D., et al. Monoallelic expression of mutant thyroid peroxidase allele causing total iodide organification defect. J. Clin. Endocrinol. Metab. 2003, 88:3264-3271.
36. Niu D.M., Lin C.Y., Hwang B., et al. Contribution of genetic factors to neonatal transient hypothyroidism. Arch. Dis. Child. Fetal. Neonatal. Ed. 2005, 90:F69-F72.
37. Agrawal P., Ogilvy-Stuart A., Lees C. Intrauterine diagnosis and management of congenital goitrous hypothyroidism. Ultrasound. Obstet. Gynecol. 2002, 19:501-505.
38. Dupuy C., Ohayon R., Valent A., et al. Purification of a novel flavoprotein involved in the thyroid NADPH oxidase. Cloning of the porcine and human cDNAs. J. Biol. Chem. 1999, 274:37265-37269.
39. De Deken X., Wang D., Many M.C., et al. Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. J. Biol. Chem. 2000, 275:23227-23233.
40. Moreno J.C., Bikker H., Kempers M.J., et al. Inactivating mutations in the gene for thyroid oxidase 2 (THOX2) and congenital hypothyroidism. N. Engl. J. Med. 2002, 347:95-102.
41. Vigone M.C., Fugazzola L., Zamproni I., et al. Persistent mild hypothyroidism associated with novel sequence variants of the DUOX2 gene in two siblings. Hum. Mutat. 2005, 26:395.
42. Varela V., Rivolta C.M., Esperante S.A., et al. Three mutations (p. Q36H, p. G418fsX482, and g. IVS19-2A > C) in the dual oxidase 2 gene responsible for congenital goiter and iodide organification defect. Clin. Chem. 2006, 52:182-191.
43. Pfarr N., Korsch E., Kaspers S., et al. Congenital hypothyroidism caused by new mutations in the thyroid oxidase 2 (THOX2) gene. Clin. Endocrinol. (Oxf.) 2006, 65:810-815.
44. Ohye H., Fukata S., Hishinuma A., et al. A novel homozygous missense mutation of the dual oxidase 2 (DUOX2) gene in an adult patient with large goiter. Thyroid 2008, 18:561-566.
45. Maruo Y., Takahashi H., Soeda I., et al. Transient congenital hypothyroidism caused by biallelic mutations of the dual oxidase 2 gene in Japanese patients detected by a neonatal screening program. J. Clin. Endocrinol. Metab. 2008, 93:4261-4267.
46. Cortinovis F., Zamproni I., Persani L., et al. Prevalence of DUOX2 mutations among children affected by congenital hypothyroidism and dyshormonogenesis. Hormone. Res. 2008, 70:40.
47. Grasberger H., De Deken X., Miot F., et al. Missense mutations of dual oxidase 2 (DUOX2) implicated in congenital hypothyroidism have impaired trafficking in cells reconstituted with DUOX2 maturation factor. Mol. Endocrinol. 2007, 21:1408-1421.
48. Grasberger H., RefetoffS. Identification of the maturation factor for dual oxidase. Evolution of an eukaryotic operon equivalent. J. Biol. Chem. 2006, 281:18269-18272.
49. Zamproni I., Grasberger H., Cortinovis F., et al. Biallelic inactivation of the dual oxidase maturation factor 2 (DUOXA2) gene as a novel cause of congenital hypothyroidism. J. Clin. Endocrinol. Metab. 2008, 93:605-610.
50. Friedman J.E., Watson J.A., Lam D.W., et al. Iodotyrosine deiodinase is the first mammalian member of the NADH oxidase/flavin reductase superfamily. J. Biol. Chem. 2006, 281:2812-2819.
51. Gnidehou S., Caillou B., Talbot M., et al. Iodotyrosine dehalogenase 1 (DEHAL1) is a transmembrane protein involved in the recycling of iodide close to the thyroglobulin iodination site. Faseb. J. 2004, 18:1574-1576.
52. McGirr E.M., Hutchison J.H. Radioactive-iodine studies in non-endemic goitrous cretinism. Lancet 1953, 1:1117-1120.
53. Moreno J.C., Klootwijk W., van Toor H., et al. Mutations in the iodotyrosine deiodinase gene and hypothyroidism. N. Engl. J. Med. 2008, 358:1811-1818.
54. Afink G., Kulik W., Overmars H., et al. Molecular characterization of iodotyrosine dehalogenase deficiency in patients with hypothyroidism. J. Clin. Endocrinol. Metab. 2008, 93:4894-4901.
55. De Maegd M., Van Nevel C. [Hypothyroidism caused by congenital familial defect of iodotyrosine deiodation]. Acta. Paediatr. Belg. 1970, 24:115-120.
56. Hirsch H.J., Shilo S., Spitz I.M. Evolution of hypothyroidism in familial goitre due to deiodinase deficiency: report of a family and review of the literature. Postgrad. Med. J. 1986, 62:477-480.